Bayer Aktiengesellschaft Website

Bayer Aktiengesellschaft

XTRA-BAYN

Basic

  • Market Cap

    €26.6B

  • EV

    €68.3B

  • Shares Out

    982.42M

  • Revenue

    €47.01B

  • Employees

    98,189

Margins

  • Gross

    58.57%

  • EBITDA

    24.41%

  • Operating

    16.84%

  • Pre-Tax

    -3.48%

  • Net

    -6.63%

  • FCF

    8.05%

Returns (5Yr Avg)

  • ROA

    -0.79%

  • ROTA

    -13.55%

  • ROE

    -2.42%

  • ROCE

    7.68%

  • ROIC

    5.1%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €36.18

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €4,725M

  • Net Debt

    €41.54B

  • Debt/Equity

    1.29

  • EBIT/Interest

    6.45

Growth (CAGR)

  • Rev 3Yr

    4.77%

  • Rev 5Yr

    3.36%

  • Rev 10Yr

    1.57%

  • Dil EPS 3Yr

    -31.94%

  • Dil EPS 5Yr

    25.68%

  • Dil EPS 10Yr

    -2.7%

  • Rev Fwd 2Yr

    0.26%

  • EBITDA Fwd 2Yr

    0.42%

  • EPS Fwd 2Yr

    -6.91%

  • EPS LT Growth Est

    -1.59%

Dividends

  • Yield

  • Payout

    -3.46%

  • DPS

    €0.11

  • DPS Growth 3Yr

    -61.97%

  • DPS Growth 5Yr

    -47.66%

  • DPS Growth 10Yr

    -25.54%

  • DPS Growth Fwd 2Yr

    0.14%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

43,545

41,400

44,081

50,739

47,637

47,013

Total Revenues % Chg.

18.5%

-4.9%

6.5%

15.1%

-6.1%

-6.9%

Cost of Goods Sold, Total

16,423

15,727

17,045

18,886

19,746

19,476

Gross Profit

27,122

25,673

27,036

31,853

27,891

27,537

Selling General & Admin Expenses, Total

14,801

13,886

14,531

16,036

14,714

14,490

R&D Expenses

5,282

4,884

5,326

6,168

5,835

5,690

Other Operating Expenses

59

-69

-296

528

-457

-561

Other Operating Expenses, Total

20,142

18,701

19,561

22,732

20,092

19,619

Operating Income

6,980

6,972

7,475

9,121

7,799

7,918

Interest Expense, Total

-1,689

-1,500

-930

-1,058

-1,134

-1,227

Interest And Investment Income

294

202

346

379

484

484

Net Interest Expenses

-1,395

-1,298

-584

-679

-650

-743

Income (Loss) On Equity Invest.

160

-96

49

-150

-162

-139

Currency Exchange Gains (Loss)

58

-216

-385

-219

-449

-505

Other Non Operating Income (Expenses)

-3

102

-384

-844

-788

-845

EBT, Excl. Unusual Items

5,800

5,464

6,171

7,229

5,750

5,686

Restructuring Charges

Merger & Related Restructuring Charges

Impairment of Goodwill

-208

-2,238

-734

-6,690

-6,690

Gain (Loss) On Sale Of Investments

30

541

-3

-450

-184

-135

Gain (Loss) On Sale Of Assets

Asset Writedown

439

126

218

1,691

152

152

Insurance Settlements

Legal Settlements

-546

-13,330

-3,689

-791

-889

-889

Other Unusual Items

-2,662

-7,813

-651

-2,275

240

240

EBT, Incl. Unusual Items

2,853

-17,250

2,046

4,670

-1,621

-1,636

Income Tax Expense

443

-1,689

1,024

504

1,321

1,486

Earnings From Continuing Operations

2,410

-15,561

1,022

4,166

-2,942

-3,122

Earnings Of Discontinued Operations

1,700

5,074

Minority Interest

-19

-8

-22

-16

1

3

Net Income

4,091

-10,495

1,000

4,150

-2,941

-3,119

Net Income to Common Incl Extra Items

4,091

-10,495

1,000

4,150

-2,941

-3,119

Net Income to Common Excl. Extra Items

2,391

-15,569

1,000

4,150

-2,941

-3,119

Total Shares Outstanding

982.4

982.4

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding

981.7

982.4

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding Dil

981.7

982.4

982.4

982.4

982.4

982.4

EPS

4.2

-10.7

1

4.2

-3

-3.2

EPS Diluted

4.2

-10.7

1

4.2

-3

-3.2

EBITDA

10,810

10,030

10,877

12,705

11,331

11,477

Effective Tax Rate

15.5%

9.8%

50%

10.8%

-81.5%

-90.8%